Integral Protocol: Core and Supportive Modalities
Functional medicine framework. Adjunct to ongoing traditional neurological care.
Umbilical Cord Mesenchymal Stem Cells
Central component of the protocol. Umbilical cord mesenchymal stem cells are utilized for their immunomodulatory properties. Objective: support tissue homeostasis and regulatory mechanisms. Minimally invasive administration. Investigational context, institutional oversight.
Learn MorePhysical Therapy · Functional Support
Individualized physical rehabilitation to maintain functional capacity, reduce secondary complications, and support mobility. Integrated with regenerative therapy to address quality of life. Evidence-based, performed by licensed therapists.
Explore ProtocolsNutritional Medicine · Cellular Substrates
Assessment of metabolic status, nutritional guidance to provide essential substrates. Focus on metabolic optimization and support for physiological repair mechanisms. Concurrent with conventional dietary management.
Get Your Personalized Plan
Clinical Framework · ALS Slowing Progression
This protocol operates within a functional medicine model, emphasizing physiological support and quality of life. It is not a curative intervention. Designed as an integral part of current and ongoing traditional medicine therapy. Characteristics:
- Comprehensive medical evaluation and neurological coordination
- Integration with patient’s existing multidisciplinary ALS care
- Minimally invasive techniques for stem cell administration
- Physical therapy and nutritional medicine as supportive therapies
- Transparent communication: supportive, to improve your quality of life and slow down progression of the disease
Therapeutic Rationale and Mechanism
The selection of umbilical cord-derived mesenchymal stem cells is based on their documented immunomodulatory capabilities. These cells secrete various bioactive molecules that may influence the local inflammatory environment in neural tissues.
When integrated with physical therapy, which aims to maintain functional capacity and reduce secondary complications, and nutritional medicine targeting metabolic optimization, this approach represents a comprehensive strategy rather than a singular intervention.
The minimally invasive administration techniques are chosen to maximize cellular delivery while minimizing patient discomfort and procedural risk, consistent with contemporary medical practice standards for cellular therapies.
Meet Our Doctors →Scientific Illustration
of Mechanism
Clinical Eligibility Considerations
Our clinical team evaluates several factors when considering patients for this integral therapeutic approach. The following represents general considerations that guide our patient assessment process:
- Documented diagnosis of ALS by neurological specialists
- Comprehensive medical evaluation to assess overall health status
- Absence of contraindications to cellular therapy procedures
- Commitment to participate in all three therapeutic components
- Realistic understanding of therapeutic goals and timeframe
- Willingness to undergo necessary pre-therapy assessments
- Supportive to existing multidisciplinary ALS care team
It is important to emphasize that individual eligibility determinations are made only after thorough medical evaluation and consultation with our clinical team. This approach is not appropriate for all patients with ALS, and traditional medical management remains the standard of care for most individuals.
Patients considering this approach should maintain their current ALS management regimen until a complete evaluation and therapeutic plan has been established with our medical team.
Clinical Evaluation · ALS Protocol
Comprehensive medical assessment prior to protocol consideration
Primary Consultation
Medical evaluation with our regenerative medicine specialist. Review of evaluation of current treatments followed. Determination of eligibility within functional medicine framework.
Clinical Education Session
Detailed discussion of protocol components, procedural steps, supportive therapies, realistic goals and expectations. Opportunity for questions.
Medical Records Review
Preliminary assessment of neurological records, prior interventions, and current functional status. Conducted by medical staff to determine if full therapy is appropriate.